Dr. Celano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-520-5000
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Neurological Surgery, 2017 - 2024
- Emory University School of MedicineInternship, Surgery, 2016 - 2017
- Emory UniversityMD, Neurosurgery, 2012 - 2016
- Emory University School of MedicineClass of 2016
Certifications & Licensure
- WA State Medical License 2024 - 2026
- DC State Medical License 2017 - 2024
Publications & Presentations
PubMed
- Efficacy of Acetazolamide for Treatment of Iatrogenic, Traumatic, and Spontaneous Cerebrospinal Fluid Leaks of the Anterior Skull Base: A Systematic Review.Spencer L Raub, Zachary A Abecassis, Thomas A Hanks, Kyly Hiatt, Aria Jamshidi
Cureus. 2024-12-01 - 1 citationsIdiopathic Pediatric Tibial Nerve Palsy.Emma Celano, Christopher M. Fleury, Esperanza Mantilla-Rivas, Jacob S. Nasser, Tiffany N Phan
Plastic and Reconstructive Surgery. Global Open. 2021-03-15 - 1 citationsCervical intradural disc herniation, case report and reflection on preoperative imaging.Emma C. Celano, Anousheh Sayah, Kevin M. McGrail
Radiology Case Reports. 2019-07-04
Journal Articles
- Spinal cord ependymoma: a review of the literature and case series of ten patientsCelano EC, Salehani A, Malcolm JG, Reinertsen E, Hadjipanayis CG, Journal of Neuro-Oncology, 5/6/2016
- Perception of passage through openings depends on the size of the body in motionFranchak JM, Celano EC, Adolph KE, Experimental Brain Research, 9/19/2012
Abstracts/Posters
- Phase I Trial of Dose-Escalating Temozolomide Plus Bevacizumab and Bortezomib for Progressive GlioblastomaMcCracken DJ, Celano EC, Voloschin A, Read W, Olson JJ, AANS Annual Scientific Meeting, Chicago, IL, 5/2/2016
- Phase I Trial of Dose-Escalating Temozolomide Plus Bevacizumab and Bortezomib for Progressive GlioblastomaMcCracken DJ, Celano EC, Voloschin A, Read W, Olson JJ, Georgia Neurosurgical Society Fall Meeting, Georgia, 12/5/2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: